RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Liver Reperfusion Injury
Accession: DOID:9002159
browse the term
Definition: Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the liver, including swelling; hemorrhage; necrosis; and damage from free radicals.
Synonyms: exact_synonym: Hepatic Ischemia-Reperfusion Injury; Hepatic Reperfusion Injury; Liver Ischemia-Reperfusion Injury
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:23762489
RGD:8695935
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADM
adrenomedullin
treatment
ISO IDA
mRNA,protein:increased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA:increased expression:liver
RGD
PMID:21431875
RGD:10402078
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
ALDH2
aldehyde dehydrogenase 2 family member
treatment
ISO
protein:altered expression:liver (mouse) protein:altered expression:liver (rat)
RGD
PMID:30671488 PMID:29589772
RGD:15036807 , RGD:14975297
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ATF6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
G
ATG13
autophagy related 13
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr11:46,617,553...46,674,518
Ensembl chr11:46,617,527...46,674,818
G
ATG16L1
autophagy related 16 like 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 2:233,251,673...233,295,669
Ensembl chr 2:233,210,051...233,295,674
G
ATG4D
autophagy related 4D cysteine peptidase
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:10,543,904...10,553,418
Ensembl chr19:10,543,895...10,553,418
G
ATG7
autophagy related 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:22847887
RGD:10053673 , RGD:10053710
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
ameliorates treatment
ISO
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:34144219 PMID:21092002 PMID:22847887
RGD:10053673 , RGD:329812011 , RGD:5134995 , RGD:10053710
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
treatment ameliorates
ISO
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887 PMID:34144219 PMID:21092002
RGD:10053710 , RGD:329812011 , RGD:5134995
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
treatment
ISO
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887
RGD:10053710
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BECN1
beclin 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
C3
complement C3
treatment
ISO
RGD
PMID:19854450
RGD:11040888
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CASP12
caspase 12 (gene/pseudogene)
treatment
ISO
RGD
PMID:29428101
RGD:13782166
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:23423194 PMID:15300206
RGD:8661760 , RGD:14695087
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
treatment ameliorates
ISO
RGD
PMID:23364428 PMID:34144219
RGD:13782358 , RGD:329812011
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCL2
C-C motif chemokine ligand 2
ameliorates treatment severity
ISO
mRNA, protein:increased expression:liver, serum (rat)
RGD
PMID:9500701 PMID:34400126 PMID:10630515 PMID:27229110
RGD:8549627 , RGD:329902072 , RGD:14995929 , RGD:14995460
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
treatment severity
ISO
RGD
PMID:28623253 PMID:28623253
RGD:14995305 , RGD:14995305
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCL7
C-C motif chemokine ligand 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCR1
C-C motif chemokine receptor 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR2
C-C motif chemokine receptor 2
severity
ISO
RGD
PMID:27229110
RGD:14995460
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CD14
CD14 molecule
ISO
RGD
PMID:22564590
RGD:7183676
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:14741776
RGD:8547795
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CFH
complement factor H
treatment
ISO IDA
mRNA,protein:decreased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
G
CS
citrate synthase
ISO
RGD
PMID:25416448
RGD:13504849
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
G
CST3
cystatin C
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CXCL1
C-X-C motif chemokine ligand 1
ameliorates treatment
ISO
RGD
PMID:21092002 PMID:21092002 PMID:34400126
RGD:5134995 , RGD:5134995 , RGD:329902072
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
treatment ameliorates
ISO
RGD
PMID:18041715 PMID:34400126
RGD:27095942 , RGD:329902072
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL6
C-X-C motif chemokine ligand 6
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL9
C-X-C motif chemokine ligand 9
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
DDIT3
DNA damage inducible transcript 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
EIF2AK3
eukaryotic translation initiation factor 2 alpha kinase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
G
ELANE
elastase, neutrophil expressed
ISO
RGD
PMID:10588515
RGD:10450560
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
G
EPO
erythropoietin
treatment
IDA
RGD
PMID:25769561
RGD:15090809
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
EPOR
erythropoietin receptor
ISO
protein:increased phosphorylation:liver:
RGD
PMID:25769561
RGD:15090809
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
G
F3
coagulation factor III, tissue factor
treatment
ISO
RGD
PMID:11750579
RGD:11341708
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:23423194
RGD:8661760
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
FAS
Fas cell surface death receptor
treatment
ISO
protein:increased expression:liver
RGD
PMID:17235585 PMID:18561025 PMID:16222447
RGD:2290283 , RGD:14700680 , RGD:1600351
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:18561025
RGD:14700680
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FGA
fibrinogen alpha chain
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:23503399
RGD:9685021
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FN1
fibronectin 1
ISO
RGD
PMID:12651615
RGD:7205470
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:22564598 PMID:13678701
RGD:329970282 , RGD:329970285
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO
associated with nonalcoholic fatty liver disease
RGD
PMID:28807209
RGD:13792730
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSTM1
glutathione S-transferase mu 1
ISO
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
H2AX
H2A.X variant histone
treatment
ISO
RGD
PMID:23792534
RGD:8693718
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
HMGB1
high mobility group box 1
treatment
ISO
mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm protein:increased oxidation:liver
RGD
PMID:24578610 PMID:21431875 PMID:22514737
RGD:10402068 , RGD:10402078 , RGD:10402175
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:20446775
RGD:10755725
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HP
haptoglobin
treatment
ISO
RGD
PMID:17187421 PMID:21699906
RGD:1626366 , RGD:11041815
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
associated with Intestinal Reperfusion Injury;protein:increased expression:liver
RGD
PMID:7884306 PMID:8780571
RGD:11520784 , RGD:14402044
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:28938192
RGD:14985248
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
RGD
PMID:22381173
RGD:12791280
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:21911118
RGD:7364839
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:25919765 PMID:14999688
RGD:14696667 , RGD:14696668
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL18BP
interleukin 18 binding protein
ISO
mRNA,protein:increased expression:liver
RGD
PMID:25919765
RGD:14696667
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
IL1A
interleukin 1 alpha
treatment
ISO
mRNA:increased expression:lung protein:increased expression:serum
RGD
PMID:19595018 PMID:9840148 PMID:19283466
RGD:2314952 , RGD:11059517 , RGD:6907377
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
ameliorates treatment
ISO
associated with Cholestasis
RGD
PMID:21468628 PMID:34400126 PMID:32155285
RGD:7175318 , RGD:329902072 , RGD:155260323
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
treatment
IDA ISO
rat model treated with human protein
RGD
PMID:9000676 PMID:12451245
RGD:6909138 , RGD:8551710
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL6
interleukin 6
treatment ameliorates
ISO
RGD
PMID:24752458 PMID:34400126 PMID:34144219 PMID:32155285
RGD:11062134 , RGD:329902072 , RGD:329812011 , RGD:155260323
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRF8
interferon regulatory factor 8
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
ITGAM
integrin subunit alpha M
treatment exacerbates
ISO
protein:increased expression:neutrophil (rat)
RGD
PMID:8387952 PMID:11447039
RGD:329901847 , RGD:329901849
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:22288937
RGD:10403073
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
LAMP2
lysosomal associated membrane protein 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
G
LBP
lipopolysaccharide binding protein
ISO
mRNA, protein:increased expression:liver
RGD
PMID:12134092
RGD:9685192
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ameliorates exacerbates
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:30076625 PMID:30622220
RGD:155804280 , RGD:155882441
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAPK8
mitogen-activated protein kinase 8
ISO
protein:increased activity:liver:
RGD
PMID:11679968
RGD:10412680
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MFN2
mitofusin 2
treatment
ISO
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:27363631 PMID:24898700
RGD:12910833 , RGD:13204829
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
G
MIR145
microRNA 145
ISO
mRNA:decreased expression:small intestine (rat)
RGD
PMID:23166305
RGD:155230822
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
G
MIR155
microRNA 155
ISO
RGD
PMID:28640790
RGD:21079442
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR21
microRNA 21
ISO
RNA:increased expression:liver
RGD
PMID:29187695
RGD:41410824
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR210
microRNA 210
treatment
ISO
RGD
PMID:32155285
RGD:155260323
NCBI chr11:568,089...568,198
Ensembl chr11:568,089...568,198
G
MIR223
microRNA 223
ISO
RNA:increased expression:liver RNA:increased expression:serum,liver
RGD
PMID:19104939 PMID:28646120
RGD:13831297 , RGD:21408574
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR34A
microRNA 34a
ISO
miRNA:increased expression:liver
RGD
PMID:28963950
RGD:14695005
NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
G
MMP15
matrix metallopeptidase 15
ISO
mRNA:increased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901
G
MMP9
matrix metallopeptidase 9
treatment
ISO
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver
RGD
PMID:17255325
RGD:8547976
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC1
mucin 1, cell surface associated
ISO
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC17
mucin 17, cell surface associated
ISO
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 7:101,020,081...101,058,859
Ensembl chr 7:101,020,072...101,058,859
G
MUC4
mucin 4, cell surface associated
ISO
mRNA:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 3:195,746,771...195,811,929
Ensembl chr 3:195,746,765...195,811,973
G
NFATC1
nuclear factor of activated T cells 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:36092961
RGD:268357360
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22288937 PMID:31952110
RGD:10403073 , RGD:21201304
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NOS3
nitric oxide synthase 3
treatment
ISO
RGD
PMID:28966130
RGD:13450941
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
PF4
platelet factor 4
exacerbates
ISO
RGD
PMID:25440775
RGD:329901829
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
IEP IDA
RGD
PMID:12605111 PMID:18507760
RGD:11100021 , RGD:11100046
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
RAB10
RAB10, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 2:26,033,285...26,137,454
Ensembl chr 2:26,034,084...26,137,454
G
RAB8B
RAB8B, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr15:63,189,606...63,267,776
Ensembl chr15:63,189,560...63,267,776
G
SELPLG
selectin P ligand
ameliorates
ISO
RGD
PMID:16365457
RGD:401717523
NCBI chr12:108,621,895...108,633,894
Ensembl chr12:108,621,895...108,633,894
G
SERPINC1
serpin family C member 1
treatment
ISO IDA
RGD
PMID:24726586 PMID:8589354
RGD:10450597 , RGD:11038771
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
ISO
protein:increased activity:plasma (rat)
RGD
PMID:12353078
RGD:8547901
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPING1
serpin family G member 1
treatment
IDA
RGD
PMID:16367929
RGD:1580273
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:24557422
RGD:9497542
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SLPI
secretory leukocyte peptidase inhibitor
ISO
RGD
PMID:19595018
RGD:2314952
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SOD1
superoxide dismutase 1
treatment
IMP
human gene in a rat model
RGD
PMID:16555330 PMID:11779401
RGD:8655889 , RGD:1581095
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD3
superoxide dismutase 3
treatment
IMP
human gene in a rat model
RGD
PMID:11779401
RGD:1581095
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
TERT
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:19545665
RGD:11038676
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TFPI
tissue factor pathway inhibitor
IDA
RGD
PMID:9921794
RGD:11062061
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:16038046 PMID:25769561
RGD:15090805 , RGD:15090809
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
G
TLR4
toll like receptor 4
treatment severity
ISO
mRNA:increased expression:liver protein:increased expression:membrane raft:
RGD
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547
RGD:10402078 , RGD:5685379 , RGD:14697702 , RGD:14697699 , RGD:14697698
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:serum (rat)
RGD
PMID:24726586 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
RGD:10450597 , RGD:155260323 , RGD:2325259 , RGD:15039406 , RGD:14995473 , RGD:14995447 , RGD:14985258 , RGD:14985257 , RGD:14696803
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
protein:increased localization:mitochondrion
RGD
PMID:23423194
RGD:8661760
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TRADD
TNFRSF1A associated via death domain
treatment
ISO
RGD
PMID:23423194
RGD:8661760
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
G
UCP2
uncoupling protein 2
ISO
mRNA:increased expression:liver
RGD
PMID:22195248
RGD:7175309
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
G
VEGFA
vascular endothelial growth factor A
ISO
RGD
PMID:26451003
RGD:15036791
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:24768926
RGD:13209011
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all